MedPath

江苏泰康生物医药有限公司

Ownership
-
Established
2008-07-30
Employees
-
Market Cap
-
Website
http://www.t-mab.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Albipagrastim alfa for Injection

Product Name
迈粒生
Approval Number
国药准字S20250021
Approval Date
May 27, 2025
NMPA

Denosumab Injection

Product Name
迈卫健
Approval Number
国药准字S20240010
Approval Date
Jul 31, 2024
NMPA

Denosumab Injection

Product Name
地舒单抗注射液
Approval Number
国药准字S20233111
Approval Date
Jun 7, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.